Resources

Featured

Pharmacy Benefit Managers: The Hidden Drivers of Cost

Biomarker Testing in Alzheimer’s

Delays in Diagnosing and Treating Hypertrophic Cardiomyopathy

Federal Approvals Open Doors to New Treatments

Add Your Heading Text Here

There’s no ‘Moonshot’ or ‘Warp Speed’ for rare diseases. There should be

Add Your Heading Text Here

Accelerated Approval Prioritizes Patients’ Access to Promising Treatments

Add Your Heading Text Here

Medicare Revisits PET Scan Restrictions for Alzheimer’s Patients

Add Your Heading Text Here

2022 Neurological Disease Working Group Meeting Summary

Add Your Heading Text Here

2022 Meeting Summary

Add Your Heading Text Here

Visit Health Policy Today

Read the latest blogs in patient-centered care.

Join AfPA

Ready to advance patient-centered care?

Quick Links

Connect

Subscribe

Get the latest health policy insights directly in your inbox

By subscribing, you agree to our privacy policy and consent to receive updates about patient access advocacy.

© 2026 Alliance for Patient Access. All rights reserved.